Our Science
World-leading capabilities in multiplexable gene editing
Genome editing for immune-privileged features
Press Releases
Qihan Biotech Publishes First Clinical Xenotransplantation Prototype, ‘Pig 3.0’, in Nature Biomedical Engineering
In a leap forward for immune privileged cell and organ therapy, researchers create first clinical xenotransplantation prototype with enhanced human immune compatibility and without active porcine endogenous retrovirus (PERV).
1 / 3
Press Releases
Co-founder Dr. George Church visited Qihan to lead SAB meetings
On October 23, 2019, Dr. George Church visited Qihan, and he learned about the team’s research progress and gave a scientific speech on cutting-edge gene-editing technology.
1 / 3
Press Releases
Qihan Biotech named in MIT Technology Review List of 50 Smartest Companies in China 2019
MIT Technology Review released their list of the "50 Smartest Companies in China 2019" . Qihan Bio was named on the TR50 list.
1 / 3
Join Our Team
Contact Us
Address: Xiaoshan District, Hangzhou, Zhejiang, China
Zipcode: 311231
TEL: 0571-83500380
FAX: 0571-83500370